RaySearch Laboratories AB Series B

2.27 £
0.80 %

RaySearch Laboratories AB développe des logiciels innovants pour le traitement du cancer par radiothérapie, fournissant des solutions pour la planification et l'optimisation des traitements.

Performance & Momentum

6 Months 2.22 %
1 Year 29.41 %
3 Years 239.79 %
5 Years 151.97 %

Similar stocks to RaySearch Laboratories AB Series B

Anantys Community

Be the first to share your analysis on RaySearch Laboratories AB Series B.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases